Healthcare
Transnational Cannabis Ltd.(TRCNF)
Live Price
Offline$0.00004
+0.00% today
1Y Change
-96.00%
Window
Jun 23, 2025 → Jun 17, 2026
- Market Cap
- —
- Revenue Growth
- 0.0%
- EPS Growth
- -522.9%
- Dividend Yield
- 0.0%
Coverage: 249 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Transnational Cannabis Ltd. (TRCNF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 96.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -522.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -522.9%, free cash flow -1669.6% with operating margin 0.0% and ROIC -60.5%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TRCNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -522.9%, with operating margin around 0.0%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TRCNF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TRCNF Max Drawdown
-96.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TRCNF and SPY.
Company Overview
Transnational Cannabis Ltd.
Other OTC
Transnational Cannabis Ltd., through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and transport cannabis and derivative products; and engages in procuring and distributing medical cannabis products and cannabis derivatives. The company has strategic partnerships with Green Tree International Inc., Auxly Cananbis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. The company was formerly known as ICC International Cannabis Corp. and changed its name to TRANSNATIONAL CANNABIS LTD in February 2020. TRANSNATIONAL CANNABIS LTD was incorporated in 2006 and is headquartered in Vancouver, Canada.
- Leadership
- David Shpilt
- IPO Date
- Aug 28, 2018
- Street Address
- 789 West Pender Street
- Mailing
- Vancouver, BC, V6C 1H2
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- 604-687-2038
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- —
- Price/Book
- 0.0
Growth
- Revenue
- 0.0%
- EPS
- -522.9%
- Free Cash Flow
- -1669.6%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -192.2%
- ROIC
- -60.5%
Balance Sheet
- Debt/Equity
- 0.09
- Current Ratio
- 1.40
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.